Inactive Instrument

Celexus, Inc.

CXUS

US15103Y1091

Celexus, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020

September 28, 2021 at 04:41 pm EDT

Celexus, Inc. announced earnings results for the full year ended March 31, 2020. For the full year, the company announced operating loss was USD 5,873 compared to USD 18,445 a year ago. Net loss was USD 8,951 compared to USD 21,234 a year ago.

Latest news about Celexus, Inc.

Celexus, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020	21-09-28	CI
Celexus, Inc. Auditor Raises 'Going Concern' Doubt	21-09-27	CI
TelUPay Signs MoU with Xytrix Systems Corporation to Manufacture Self-Service Payment Kiosks	15-03-10	CI
TeluPay International Inc. Launches International Remittance Platform with Artajasa	14-11-05	CI
Telupay International Inc. Auditor Raises 'Going Concern' Doubt	14-07-16	CI
Telupay International Inc. Accepts the Resignation of Jose Luis Romero-Salas as Director	14-06-26	CI
Telupay International Inc. will Change its Ticker to TLPY from ILVLD	13-11-18	CI
I-Level Media Group, Inc. will Change its Ticker to ILVLD from ILVL	13-10-22	CI
I-Level Media Group Incorporated will Change its Name to Telupay International Inc	13-10-22	CI
Telupay International Inc. has Changed its Ticker to ILVL.D from ILVL	13-10-22	CI
I-Level Media Group, Inc. Announces Change in Fiscal Year End	13-09-30	CI
Telupay International Inc. Auditor Raises 'Going Concern' Doubt	13-09-29	CI
TeluPay PLC completed the acquisition of i-Level Media Group, Inc. in a reverse merger transaction.	13-09-24	CI
Telupay International Inc. Auditor Raises 'Going Concern' Doubt	13-01-22	CI

Chart Celexus, Inc.

Duration

Period

More charts

Company Profile

Celexus, Inc. is a shell company. The Company is an acquisition, management and holding company for early stage businesses and technologies in the hemp industry. It is focused on the new opportunities available for the growth of hemp. It intends to acquire entities that will be able to cultivate, help and produce seeds and clones for other cultivators. The Company has not started its principal operations.

Sector

Pharmaceuticals

More about the company